What do you want to ask the ISCT 2021 Presidential Plenary panelists?

Dr. Bruce Levine and Dr. Shabnum Patel will co-chair the ISCT 2021 Presidential Plenary Session on May 26, titled Integrating Science, Regulatory Oversight, and Commercialization for the New Wave of Cell and Gene Therapies.

They want to hear from you! What does the ISCT community want to ask the esteemed panelists about the cell and gene therapy industry?

Submit your questions for the panel using the form below.

Peter Marks, MD, PhD
Director, Center for Biologics
Evaluation and Research, FDA
United States

Arie Belldegrun, MD, FACS
Founder, Kite Pharma
Executive Chairman, Allogene
United States

Matthew Porteus

Matthew Porteus, MD, PhD
Co-Founder, CRISPR Therapeutics & Graphite Bio
Stanford University
United States

Bruce Levine

Bruce Levine, PhD
Session Co-Chair
President, ISCT
University of Pennsylvania
United States

“For some time now, we have been lining up to build the research and the knowledge needed for cell and gene therapies to flourish, but now, the pivotal approvals and studies are beginning to happen. The questions we can ask now pivot towards how approval should be approached, how reimbursement might look, how patients can get access to therapies, and so on”

Shabnum Patel

Shabnum Patel, PhD
Session Co-Chair
ISCT Leadership Mentoring Program
Stanford University
United States

“Understanding how to successfully translate promising science, and how to navigate regulatory oversight and pathways for commercialization, will lower the barrier to accessibility and accelerate the speed at which patients can receive these life-saving therapies”